121 related articles for article (PubMed ID: 11600882)
1. Increased urinary 6-sulfatoxymelatonin excretion in women with non-classical steroid 21-hydroxylase deficiency.
Luboshitzky R; Qupti G; Ishay A; Shen-Orr Z; Herer P
Neuro Endocrinol Lett; 2001 Oct; 22(5):332-6. PubMed ID: 11600882
[TBL] [Abstract][Full Text] [Related]
2. Cyproterone acetate-ethinyl estradiol treatment alters urinary 6-sulfatoxymelatonin excretion in hyperandrogenic women.
Luboshitzky R; Herer P; Shen-Orr Z
Neuro Endocrinol Lett; 2002 Aug; 23(4):309-13. PubMed ID: 12195232
[TBL] [Abstract][Full Text] [Related]
3. Urinary 6-sulfatoxymelatonin excretion in hyperandrogenic women: the effect of cyproterone acetate-ethinyl estradiol treatment.
Luboshitzky R; Herer P; Shen-Orr Z
Exp Clin Endocrinol Diabetes; 2004 Feb; 112(2):102-7. PubMed ID: 15031776
[TBL] [Abstract][Full Text] [Related]
4. Increased 6-sulfatoxymelatonin excretion in women with polycystic ovary syndrome.
Luboshitzky R; Qupti G; Ishay A; Shen-Orr Z; Futerman B; Linn S
Fertil Steril; 2001 Sep; 76(3):506-10. PubMed ID: 11532473
[TBL] [Abstract][Full Text] [Related]
5. Hyperinsulinemia and insulin insensitivity in women with nonclassical congenital adrenal hyperplasia due to 21-hydroxylase deficiency: the relationship between serum leptin levels and chronic hyperinsulinemia.
Saygili F; Oge A; Yilmaz C
Horm Res; 2005; 63(6):270-4. PubMed ID: 15956788
[TBL] [Abstract][Full Text] [Related]
6. Adrenal androgenic response to 2-hour ACTH stimulation test in women with PCOS.
Erel CT; Senturk LM; Oral E; Colgar U; Ertungealp E
Gynecol Endocrinol; 1998 Aug; 12(4):223-9. PubMed ID: 9798131
[TBL] [Abstract][Full Text] [Related]
7. Decreased melatonin secretion in a phenotypically male 46,XX patient with classic 21-hydroxylase deficiency.
Luboshitzky R; Qupti G; Shen-Orr Z; Hardoff R
Exp Clin Endocrinol Diabetes; 2000; 108(3):237-40. PubMed ID: 10926323
[TBL] [Abstract][Full Text] [Related]
8. [Defects of adrenal steroidogenesis in patients with hirsutism].
Salinas Vert I; Audí Parera L; Granada Ybern ML; Lucas Martín A; Pizarro Lozano E; Foz Sala M; Sanmartí Sala A
Med Clin (Barc); 1998 Feb; 110(5):171-6. PubMed ID: 9547720
[TBL] [Abstract][Full Text] [Related]
9. The presence of the 21-hydroxylase deficiency carrier status in hirsute women: phenotype-genotype correlations.
Escobar-Morreale HF; San Millán JL; Smith RR; Sancho J; Witchel SF
Fertil Steril; 1999 Oct; 72(4):629-38. PubMed ID: 10521100
[TBL] [Abstract][Full Text] [Related]
10. Carriers of 21-hydroxylase deficiency are not at increased risk for hyperandrogenism.
Knochenhauer ES; Cortet-Rudelli C; Cunnigham RD; Conway-Myers BA; Dewailly D; Azziz R
J Clin Endocrinol Metab; 1997 Feb; 82(2):479-85. PubMed ID: 9024240
[TBL] [Abstract][Full Text] [Related]
11. Results of the ACTH stimulation test in hirsute women.
Erel CT; Senturk LM; Oral E; Mutlu H; Colgar U; Seyisoglu H; Ertungealp E
J Reprod Med; 1999 Mar; 44(3):247-52. PubMed ID: 10202742
[TBL] [Abstract][Full Text] [Related]
12. The incidence of non-classical 21-hydroxylase deficiency in hirsute adolescent girls.
Akinci A; Yordam N; Ersoy F; Uluşahin N; Oğuz H
Gynecol Endocrinol; 1992 Jun; 6(2):99-106. PubMed ID: 1323921
[TBL] [Abstract][Full Text] [Related]
13. 3 beta-hydroxysteroid dehydrogenase deficiency in hyperandrogenism.
Azziz R; Bradley EL; Potter HD; Boots LR
Am J Obstet Gynecol; 1993 Mar; 168(3 Pt 1):889-95. PubMed ID: 8456898
[TBL] [Abstract][Full Text] [Related]
14. Comparison of basal and adrenocorticotropin-stimulated plasma 21-deoxycortisol and 17-hydroxyprogesterone values as biological markers of late-onset adrenal hyperplasia.
Fiet J; Gueux B; Gourmelen M; Kuttenn F; Vexiau P; Couillin P; Pham-Huu-Trung MT; Villette JM; Raux-Demay MC; Galons H
J Clin Endocrinol Metab; 1988 Apr; 66(4):659-67. PubMed ID: 2831244
[TBL] [Abstract][Full Text] [Related]
15. Pituitary-ovarian responses to leuprolide acetate testing in patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
Ghizzoni L; Virdis R; Vottero A; Cappa M; Street ME; Zampolli M; Ibañez L; Bernasconi S
J Clin Endocrinol Metab; 1996 Feb; 81(2):601-6. PubMed ID: 8636275
[TBL] [Abstract][Full Text] [Related]
16. The frequency of CYP 21 gene mutations in Turkish women with hyperandrogenism.
Kelestimur F; Everest H; Dundar M; Tanriverdi F; White C; Witchel SF
Exp Clin Endocrinol Diabetes; 2009 May; 117(5):205-8. PubMed ID: 19085698
[TBL] [Abstract][Full Text] [Related]
17. Corticotropin-releasing hormone: a potent androgen secretagogue in girls with hyperandrogenism after precocious pubarche.
Ibáñez L; Potau N; Marcos MV; de Zegher F
J Clin Endocrinol Metab; 1999 Dec; 84(12):4602-6. PubMed ID: 10599726
[TBL] [Abstract][Full Text] [Related]
18. Increased plasma 21-deoxycorticosterone (21-DB) levels in late-onset adrenal 21-hydroxylase deficiency suggest a mild defect of the mineralocorticoid pathway.
Fiet J; Gueux B; Raux-DeMay MC; Kuttenn F; Vexiau P; Brerault JL; Couillin P; Galons H; Villette JM; Julien R
J Clin Endocrinol Metab; 1989 Mar; 68(3):542-7. PubMed ID: 2537337
[TBL] [Abstract][Full Text] [Related]
19. 21-Hydroxylase deficiency in female hyperandrogenism: screening and diagnosis.
Azziz R; Zacur HA
J Clin Endocrinol Metab; 1989 Sep; 69(3):577-84. PubMed ID: 2547827
[TBL] [Abstract][Full Text] [Related]
20. Adrenal 21-hydroxylase gene mutations in Slovenian hyperandrogenic women: evaluation of corticotrophin stimulation and HLA polymorphisms in screening for carrier status.
Dolzan V; Prezelj J; Vidan-Jeras B; Breskvar K
Eur J Endocrinol; 1999 Aug; 141(2):132-9. PubMed ID: 10427156
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
